Boston Scientific, Bolt

Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m
Boston Scientific initially developed the concept for the Bolt IVL system, which is engineered to fracture calcium using acoustic pressure waves within a balloon catheter. Boston
Boston Scientific announces acquisition of the remaining stake in Bolt Medical
Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices company does not already own.
Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal
Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and peripheral artery disease.
Boston Scientific Surges On $900 Million Takeover Of Bolt Medical
Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.
Boston Scientific makes IVL play with Bolt Medical acquisition
Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer Bolt Medical.
Boston Scientific to buy remaining Bolt Medical stake for up to $664M
The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.
Boston Scientific to acquire Bolt Medical for upfront payment of $443M
Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular
Boston Scientific zaps Bolt Medical in $664M intravascular lithotripsy buy
Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and its hardware for breaking through hardened and clogged arteri | Set to close within the first half of the year,
Boston Scientific Completes Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio
Acquisition Strengthens Boston Scientific's Position in Minimally Invasive Treatment for Coronary Artery Disease
Strategic Acquisition of Bolt Medical Positions Boston Scientific for Long-Term Growth in Interventional Cardiology
J.P. Morgan analyst Robbie Marcus has maintained their bullish stance on BSX stock, giving a Buy rating today.Stay Ahead of the
WBJournal2d
Boston Scientific to acquire California blood flow treatment manufacturer for up to $664M
Marlborough-based Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...
Investor's Business Daily on MSN2d
Boston Scientific Surges Into Buy Zone On $900 Million Takeover Of Bolt Medical
Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.